These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8929121)

  • 1. [Azithromycin (sumamed)--in the treatment of respiratory tract infections].
    Fomina IP; Smirnova LB; Iudin SM
    Antibiot Khimioter; 1996 Feb; 41(2):52-61. PubMed ID: 8929121
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections.
    Powers JL
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The newer macrolides: azithromycin and clarithromycin.
    Zuckerman JM
    Infect Dis Clin North Am; 2000 Jun; 14(2):449-62, x. PubMed ID: 10829265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection.
    Adeleye IA; Uwagboe UC
    West Indian Med J; 2003 Dec; 52(4):325-6. PubMed ID: 15040073
    [No Abstract]   [Full Text] [Related]  

  • 6. Azithromycin: an interim analysis.
    Ball AP
    J Int Med Res; 1991; 19(6):446-50. PubMed ID: 1663467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
    Dunn CJ; Barradell LB
    Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and clinical evaluation of azithromycin in pediatrics].
    Okumura A; Kuno K
    Jpn J Antibiot; 1996 Nov; 49(11):994-1003. PubMed ID: 8988411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: revolutionary changes in the macrolide and azalide antibiotics.
    Moellering RC
    Am J Med; 1991 Sep; 91(3A):1S-4S. PubMed ID: 1656735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Five years of sumamed on Russian market].
    Sadovnikova SF; Selina EV
    Antibiot Khimioter; 1997; 42(11):42-4. PubMed ID: 9463300
    [No Abstract]   [Full Text] [Related]  

  • 11. Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
    Davila D; Tambić T; Djokić S; Kolacny-Babić L
    Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sumamed--efficacy and convenience].
    Sirakov M; Ivanov S
    Akush Ginekol (Sofiia); 2005; 44 Suppl 2():38-42. PubMed ID: 16028403
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clarithromycin: specific features of antimicrobial spectrum and clinical use].
    Budanov SV; Vasil'ev AN
    Antibiot Khimioter; 2004; 49(2):19-25. PubMed ID: 15285409
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.
    Merchan LM; Hassan HE; Terrin ML; Waites KB; Kaufman DA; Ambalavanan N; Donohue P; Dulkerian SJ; Schelonka R; Magder LS; Shukla S; Eddington ND; Viscardi RM
    Antimicrob Agents Chemother; 2015 Jan; 59(1):570-8. PubMed ID: 25385115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field].
    Okada T; Machida Y; Fujieda M; Shimazaki Y; Kurashige T
    Jpn J Antibiot; 1996 Nov; 49(11):1024-9. PubMed ID: 8988414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
    Roord JJ; Wolf BH; Gossens MM; Kimpen JL
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of Achillea clavennae essential oil against respiratory tract pathogens.
    Skocibusić M; Bezić N; Dunkić V; Radonić A
    Fitoterapia; 2004 Dec; 75(7-8):733-6. PubMed ID: 15567252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Azithromycin--an antibiotic of the azalide group].
    Sidorenko SV
    Antibiot Khimioter; 1993 Jan; 38(1):3-9. PubMed ID: 8060181
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
    Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
    Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azithromycin (sumamed)--basic properties and therapy of community-acquired pneumonia].
    Budanov SV
    Antibiot Khimioter; 2000; 45(10):28-37. PubMed ID: 11212397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.